Enzo Biochem’s Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components

New System Adds to Company’s Investigative and Analytical Research Products FARMINGDALE, N.Y.--Enzo Life Sciences, a division of Enzo Biochem, Inc. (NYSE:ENZ), has added a novel new system to its CELLestial™ line of live cell analysis products, providing expanded capability to simultaneously image both the nucleus and the nucleolus in living cells, the Company announced today. [...]

Pressure BioSciences, Inc. Announces Changes to Its Board of Directors

SOUTH EASTON, Mass. -- Pressure BioSciences, Inc. (Nasdaq:PBIO - News) ("PBI" and the "Company") today announced that Mr. P. Thomas Vogel has resigned as a member of the Company's Board of Directors, and Mr. Alan D. Rosenson has been elected to fill the newly created vacancy, each effective Tuesday, September 15, 2009. Mr. Vogel served [...]

RainDance Technologies and CLC bio Collaborate

RainDance Technologies and CLC bio Collaborate to Develop Specialized Software Solutions for Targeted Resequencing LEXINGTON, Mass. & AARHUS, Denmark--RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next generation DNA sequencing platforms. “The rapid and [...]

Meridian Bioscience Granted Special 510(k) Clearance

Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU® Test Package Insert CINCINNATI--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the company has been granted a Special 510(k) clearance to update the TRU FLU package insert to include analytical sensitivity claims with two [...]

Fluidigm’s Upcoming Stem Cell Culture Chip Status Update At World Stem Cell Summit

Fluidigm’s Upcoming Stem Cell Culture Chip to Speed Development, Reduce Complexity and Lower Costs SOUTH SAN FRANCISCO, Calif.--Fluidigm will provide the latest updates for its upcoming Stem Cell Culture Chip at the World Stem Cell Summit being held in Baltimore on September 21 – 23. This specialized integrated fluidic circuit will enable a variety of [...]

California Stem Cell and Stemina Biomarker Discovery Announce Collaboration

California Stem Cell and Stemina Biomarker Discovery Announce Collaboration to Validate Effectiveness of Human Embryonic Stem Cell-Derived Cardiomyocyte Progenitors for Use in Predictive Toxicology - CardioPlate™ 96-well assay-ready plates enable predictive toxicology and high throughput screening assays IRVINE, Calif.--Collaboration between California Stem Cell, Inc. (CSC) and Stemina Biomarker Discovery on a study using CSC’s 96-well [...]

Roche’s xCELLigence System and FuGENE® HD Transfection Reagent

Roche’s xCELLigence System and FuGENE® HD Transfection Reagent Minimize Cytotoxic Effects in the Detection of Bax-Induced Apoptosis PENZBERG, Germany--Transfection is a way to transiently or permanently deliver nucleic acids into eukaryotic cells to study functional effects in response to altered gene expression and for protein production. In a recent study (1) the xCELLigence System for [...]

SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test

First Commercial Test from Sequenom Center for Molecular Medicine SAN DIEGO -- SEQUENOM, Inc. (Nasdaq: SQNM - News) today announced that the company's first laboratory developed test, the SensiGene(TM) Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA (Clinical Laboratory [...]

Navigenics Welcomes Michael Critelli to Board of Directors

FOSTER CITY, Calif.--Navigenics, a leading personal genomics testing company, announced today that Michael J. Critelli has been appointed to its board of directors. Upon his retirement in February 2009, Mr. Critelli completed a nearly 30-year career at Pitney Bowes Inc. where he served as CEO for 11 years and Chairman for 12 years. Under his [...]

Universal Detection Technology at ASIS International 2009

Universal Detection Technology Addresses Bioterrorism Threat to National Security at ASIS 2009 As U.S. Senate Bill Addressing Risk of Biological Attack Undergoes Revue, Company Showcases Latest in First Responder Technology with Five Agent Biodetection Kit - ASIS International’s 55th Annual Seminar and Exhibits LOS ANGELES--Universal Detection Technology (www.udetection.com)(OTCBB: UNDT), a developer of early-warning monitoring technologies [...]

Access IBO on Knowledge Center